Open Label Safety/Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) in Patients With Cervical Dystonia

NCT00702754 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

502

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Dystonia

Interventions

BIOLOGICAL: Botulinum Toxin Type B

Sponsor

Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC